Latest News

Latest News

News from the World Hepatitis Alliance

Webinar on the Global Movement to Eliminate Viral Hepatitis

27 Oct 2015 Bridie Taylor

Learn more about the global movement to eliminate viral hepatitis. On 28 th October WHA President Charles Gore and WHA Executive Board Member for the...

WHO Regional Committee meetings see regions commit to tackling viral hepatitis

23 Oct 2015 Bridie Taylor

Despite viral hepatitis impacting almost every country in the world, the burden differs significantly from region to region. In order to achieve...

Expanding the membership base of the World Hepatitis Alliance

1 Oct 2015 Bridie Taylor

The membership base of the World Hepatitis Alliance continues to go from strength to strength as we welcome five new organisations. Our membership is...

Looking ahead to the next Summit

17 Sep 2015 Bridie Taylor

Following the first World Hepatitis Summit that took place in Glasgow, Scotland 2-4 September, we are already looking ahead to the next Summit. The...

Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025

15 Sep 2015

By Keith Alcorn, Infohep.org Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global...

Medicines Patent Pool looks at hepatitis C

14 Sep 2015

By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...

World Health Organization calls for ambitious global targets for viral hepatitis control

5 Sep 2015

By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit

4 Sep 2015 Bridie Taylor

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...

World Hepatitis Summit: New data shows relentless rise in hepatitis deaths

2 Sep 2015

New data shows relentless rise in hepatitis deaths: World leaders meet in Scotland to discuss urgent response and move towards elimination of 7th...

Is the elimination of viral hepatitis on the horizon?

28 Jul 2015 Bridie Taylor

Today marks the fifth official World Hepatitis Day where members of the public and the hepatitis community provide a voice for the 4000 lives lost...

Welcoming new members to the World Hepatitis Alliance

17 Jul 2015 Bridie Taylor

Over the past few months we have welcomed a surge of new members to the World Hepatitis Alliance and we are proud to now have 216 member groups in 80...

2 weeks until World Hepatitis Day!

14 Jul 2015 Bridie Taylor

July 28 is now fast approaching and it’s set to be the biggest World Hepatitis Day yet! But we need your support to ensure we reach as many people as...

Calling for greater commitment to the fight against hepatitis at the World Health Assembly

28 May 2015 Bridie Taylor

The 68th session of the World Health Assembly (WHA68) took place in Geneva from 18th-26th May. On 25th May, the World Hepatitis Alliance was invited...

Working closely with WHO to develop a global strategy

1 Apr 2015 Bridie Taylor

WHO Strategic and Technical Advisory Committee for hepatitis (STAC-HEP) meeting, Geneva, Switzerland, 19 – 20 February As part of an expert advisory...

Supporting the launch of guidelines and policies to address viral hepatitis

1 Apr 2015 Bridie Taylor

WHO Injection Safety policy Every year 1.7 million people are infected with hepatitis B through unsafe injection and 315,000 with hepatitis C. Yet up...

Highlighting the importance of patient advocacy at international conferences

31 Mar 2015 Bridie Taylor

24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...

How will 2015 be a defining year for the Alliance?

28 Feb 2015 Bridie Taylor

Viral hepatitis is a global killer with alarming mortality rates, yet an increased global commitment to tackling the disease and ground-breaking new...

How does the Alliance really represent hepatitis patients?

28 Feb 2015 Bridie Taylor

The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...

What is the future for hepatitis treatments? And how we can fund hepatitis programmes?

28 Feb 2015 Bridie Taylor

Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...

WHA in official relations with WHO: What does this mean for you?

28 Feb 2015 Bridie Taylor

Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...

Pages

News from infohep

Georgia: 98% cured of hepatitis C

23 May 2018 Keith Alcorn
Georgia is making strong progress towards eliminating hepatitis C but will need triple the number of people starting treatment if it is to reach its...

T cell immunotherapy shows promise for treating liver cancer

22 May 2018 Liz Highleyman
Personalised immunotherapy reduces the risk of liver cancer recurrence and may lead to tumour regression, according to a pair of studies presented at...

Do fatigue and quality of life improve after hepatitis C is cured?

15 May 2018 Keith Alcorn
Patient-reported outcomes such as fatigue, vitality and mental health improve substantially in the two years following hepatitis C cure for people...

Does portal hypertension always improve after hepatitis C cure?

10 May 2018 Keith Alcorn
Although portal hypertension improves in the majority of people with hepatitis C and cirrhosis after hepatitis C is cured, not all people experience...

Combining hepatitis C therapy and buprenorphine leads to good outcomes for people who inject drugs

8 May 2018 Liz Highleyman
Offering hepatitis C treatment and opioid substitution therapy with buprenorphine at the same location can help increase adherence and reduce harms...

Switching to TAF improves safety in people with hepatitis B with kidney and bone risk factors

4 May 2018 Liz Highleyman
People with risk factors for tenofovir toxicity who switched from tenofovir disoproxil fumarate (TDF; Viread) to the new tenofovir alafenamide (TAF;...

Fewer non-liver cancers in people treated with DAAs compared to the interferon era

2 May 2018 Keith Alcorn
The risk of non-liver cancer is lower in people treated with direct-acting antivirals (DAAs) than in those treated with interferon and is probably an...

Myrcludex B plus tenofovir suppresses hepatitis delta

30 Apr 2018 Liz Highleyman
An experimental drug that blocks the entry of hepatitis B virus (HBV) and hepatitis delta virus (HDV) into liver cells suppressed HBV and HDV levels...

Sustained virological response reduces risk of serious cardiovascular disease in people with HCV-related compensated cirrhosis

27 Apr 2018 Michael Carter
Successful hepatitis C virus (HCV) therapy reduces the risk of a serious cardiovascular event in people with compensated liver cirrhosis, French...

Local therapy with sorafenib does not improve liver cancer survival

23 Apr 2018 Liz Highleyman
Combining sorafenib (Nexavar) with internal radiation therapy or transarterial chemoembolization did not improve overall survival for people with...